LearnOn Podcast: The Science Show By Kids, For Everyone!

What would it be like to dedicate over 50 years of your life towards treating a disease? Today, we're finding out with Dr. Jerry Mendell, who has been working to help patients with Duchenne muscular dystrophy since the 1960s. He is known for studying a similar disorder and partnering with Sarepta Therapeutics to create a therapy that delivers healthy copies of the dystrophin gene, which was approved by the FDA in June of 2023. Join us to hear Dr. Mendell's thoughts on applying new forms of gene therapy for this condition, extrapolating his findings to treat spinal muscular atrophy, and the onslaught of modern research becoming outdated in the context of accelerating technological developments.

Though there are many known issues with the American healthcare system, one of the most overlooked faults is that it's designed for people who stay in place. Care is often neglected or subpar for immigrants, citizens that regularly travel for work, and other people that frequently move around for various reasons. To understand why this is the case and how to fix it, we spoke with Kim Nolte, CEO of the Migrant Clinicians Network. Tune in to hear about the importance of language for effective communication in medical settings, how this organization carefully tailors resources for the individual needs of populations they serve, and the power of turning your worst moments into your best ones.
Kim Nolte joined the Migrant Clinicians Network in 2023. At MCN, she leads with her unique expertise through a master's degree in public health and multilingual experience. Prior to that, she served as the CEO of the Georgia Campaign for Adolescent Power & Potential, where she spearheaded a campaign to reduce the teen birth rate of Georgia by a third in just 5 years.
Check out MCN's website here: www.migrantclinician.org/

Tackling Alzheimer's disease has seemed to take up a lot of headlines lately - from drugs reducing the severity of symptoms to new research studies revolutionizing how we understand its causes, the media has been nothing short of enthralled by recent advances. However, the initial step of diagnosis is often overlooked despite being a key component of this story. Today, we're chatting with Dr. Venkat Shastri about how his company ALZPath developed a blood test for a protein marker to catch Alzheimer's early on and help prevent its progression. Join us to learn about how we can cut costs of expensive testing and the power of visualizing 5 to 10 years into the future!
​
Dr. Venkat Shastri is the CEO of ALZPath and the De Sanctis professor of engineering and entrepreneurship at the University of San Diego. He has a PhD in electrical and computer engineering and has been involved in many related startups. He has also previously conducted research at the NASA Jet Propulsion Laboratory and Yale University along with serving as a consulting professor at Stanford University.
Check out ALZPath: alzpath.bio/

Many of us have heard about the issue of lead pipes contaminating our water supply. Though it's been well established that this could improve the health of millions of Americans, the challenge in moving forward is deciding whether the immense upfront costs of replacing pipes is worth it from a financial standpoint. To tackle this issue, we're discussing with Ronnie Levin, a Harvard professor who previously worked at the Environmental Protection Agency (EPA). Tune in to hear about how the brilliant simplicity of her cost-benefit analysis approach pushed the EPA to commit to replacing all of the USA's lead pipes in the next decade for better health outcomes.
​Ronnie Levin is an instructor in Harvard T.H. Chan School of Public Health’s department of environmental health. In May of 2023, she published a study demonstrating that the resulting health benefits of replacing lead pipes would be around $9 billion and result in an additional minimum of $2 billion in infrastructure benefits -- all by using analysis methods she developed during her time working at the EPA for 40 years.